|
|
Develops PD1, PD-L1, Recombinant Antibodies, Immune Checkpoint Reagents, Reporter Cell lines, Inhibitors, anti-PDL1 reagents for scientific study, production of new diagnostic assays and potential therapies of human diseases.
Details: ABEOMICS develops PD1, PD-L1, Recombinant Antibodies, Immuno Check Point Reagents, Reporter Cell lines, Inhibitors, anti-PDL1 reagents for scientific study, production of new diagnostic assays and potential therapies of human diseases with biological interests on cancer, apoptosis, molecular signaling pathways, cellular aging, metabolic disorder, neuro-degenerative, genetic and infectious diseases.
URL: www.abeomics.com
Category: Biotechnology
|
| Rating: 0.00 (0 votes) Rate it |
|
